These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1257540)

  • 61. Acute rise in serum immunoglobulin E concentration in pulmonary thromboembolism.
    Takekawa H; Miyamoto K; Yamaguchi E; Munakata M; Kawakami Y
    Chest; 1993 Jul; 104(1):61-4. PubMed ID: 8325118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. On the cause of increased vascular permeability in the delayed microembolism syndrome.
    Lindquist O; Saldeen T; Svensjö E; Wallin R
    Bibl Anat; 1977; (16 Pt 2):409-11. PubMed ID: 603569
    [No Abstract]   [Full Text] [Related]  

  • 63. [Stabbing thoracic pain. Multiple lung embolisms].
    Tuma J
    Praxis (Bern 1994); 2005 Nov; 94(47):1876-8. PubMed ID: 16335312
    [No Abstract]   [Full Text] [Related]  

  • 64. Patient-Friendly Summary of the ACR Appropriateness Criteria: Acute Chest Pain-Suspected Pulmonary Embolism.
    Borondy Kitts A
    J Am Coll Radiol; 2018 Jan; 15(1 Pt A):e1. PubMed ID: 29304932
    [No Abstract]   [Full Text] [Related]  

  • 65. [On the standardization of FDP assays (author's transl)].
    Ikematsu S; Matsubara Y; Konishi S
    Rinsho Byori; 1976 Apr; 24(4):329-33. PubMed ID: 945388
    [No Abstract]   [Full Text] [Related]  

  • 66. [FDP-E fraction].
    Kazama M
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():30-3. PubMed ID: 8753173
    [No Abstract]   [Full Text] [Related]  

  • 67. Serum fibrin-fibrinogen degradation products after experimental pulmonary embolism.
    Jones DR; Ruckley CV; Owens R; Cash JD
    Br J Surg; 1974 Oct; 61(10):811-3. PubMed ID: 4415741
    [No Abstract]   [Full Text] [Related]  

  • 68. Fibrinogen degradation products in urological malignant tumors.
    Riedmiller H; Thüroff JW; Jacobi GH
    Urol Int; 1984; 39(1):13-5. PubMed ID: 6730112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Fibrinogen degradation products in pulmonary neoplastic diseases].
    Incoronato AM; Gennarelli E
    Arch Monaldi; 1975; 30(5-6):424-35. PubMed ID: 1234836
    [No Abstract]   [Full Text] [Related]  

  • 70. Serum fibrin degradation products in acute idiopathic anterior uveitis.
    Sen DK; Sarin GS; Mathur MD
    Acta Ophthalmol (Copenh); 1986 Dec; 64(6):632-6. PubMed ID: 3811876
    [TBL] [Abstract][Full Text] [Related]  

  • 71. What Are the Parameters That Should Inform Gestalt as a Clinical Decision Strategy for Pulmonary Embolism?
    Jolobe OMP
    Am J Med; 2020 Feb; 133(2):e61. PubMed ID: 31954476
    [No Abstract]   [Full Text] [Related]  

  • 72. Diagnostic Strategies for Suspected Pulmonary Embolism.
    Levi M; van Es N
    JAMA; 2021 Dec; 326(21):2135-2136. PubMed ID: 34874441
    [No Abstract]   [Full Text] [Related]  

  • 73. Age adjusted D-dimers.
    Thompson A
    Clin Med (Lond); 2019 Jan; 19(1):93. PubMed ID: 30651270
    [No Abstract]   [Full Text] [Related]  

  • 74. [Not Available].
    Righini M; Mazzolai L; Fontana P
    Rev Med Suisse; 2020 Dec; 16(718):2359-2360. PubMed ID: 33300693
    [No Abstract]   [Full Text] [Related]  

  • 75. Plasma and serum concentrations of DNA in pulmonary thromboembolism.
    Davis JS; Suratt PM
    Am Rev Respir Dis; 1982 Nov; 126(5):940-1. PubMed ID: 7149463
    [No Abstract]   [Full Text] [Related]  

  • 76. [Serum contraction of FDP (fibrin degradation products) in acute pulmonary embolism].
    Patiño R; Corral EF; Cerda E; de la Serna JL; Durán Sacristán M
    Rev Esp Cardiol; 1976; 29(1):3-8. PubMed ID: 1257540
    [No Abstract]   [Full Text] [Related]  

  • 77. [Fibrinogen degradation products in acute pulmonary thromboembolism].
    Grau A; Cabrer B; Bofill D; Montis T; Maragall S; Vivancos J; Balcells A
    Rev Clin Esp; 1976 Jul; 142(2):131-4. PubMed ID: 968099
    [No Abstract]   [Full Text] [Related]  

  • 78. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Fibrin/fibrinogen degradation products in the diagnosis of pulmonary thromboembolism].
    Ena IaM; Drannik GN; Konopleva LF
    Ter Arkh; 1985; 57(4):143-6. PubMed ID: 3892752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.